ORLADEYO

berotralstat hydrochloride · BioCryst Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ORLADEYO, covering 2020-12-03 to 2026-02-18. Get the full timeline:

Most recent: EMA Authorised: Orladeyo (berotralstat dihydrochloride) — BioCryst Ireland Limited